TorQuest Partners announces the acquisition of Bartek Ingredients Inc., a specialty products manufacturer specializing in malic acid, fumaric acid, and maleic anhydride for food and beverage, animal nutrition, and industrial applications.
Bartek is a global leader in fumaric acid production, which can be used as a replacement for antibiotics in animal feed and increases feed conversion in piglets in the post-weaning period. The acquisition will allow for increased capabilities and capacity.
“Cost-in-use remains a major opportunity for both human and animal nutrition brands to deliver a quality product with cost efficiency,” says incoming CEO John Burrows. “Whether seeking to improve taste, create operational efficiencies, or make a more effective product, we help our customers apply our specialty products to achieve their objectives.”
Supporting its production of malic and fumaric acid ingredients, Bartek also manufactures maleic anhydride, a versatile intermediary chemical. Used in the production of malic and fumaric acids, maleic anhydride also supports the production of a wide range of industrial products—copolymers, surfactants, and more.
With a focused product portfolio delivering wide-ranging benefits, Bartek’s specialty products improve taste, efficiency, and efficacy for brands around the globe. Supported by TorQuest and with new leadership, Bartek intends to continue its growth trajectory.
“TorQuest values Bartek’s proven capabilities and is committed to providing capital equity to support the next stage of Bartek’s growth,” said Chapman.
For more information about Bartek and its products, visit bartek.ca.
